Rinat Yacobi
- Hematology top 2%
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 5%
- Oncology top 10%
- Rheumatology top 5%
- Co-authors
- Richard A. Van EttenFred J. ClubbJean‐Bernard DurandLuanda GrazetteRisto KerkeläSergei ShevtsovRobert SalomonJoseph Alroy
- Topics
- Lung Cancer Treatments and Mutations (4 papers)Eosinophilic Disorders and Syndromes (2 papers)Chronic Myeloid Leukemia Treatments (2 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- IsraelCanadaUnited States
In The Last Decade
Rinat Yacobi
11 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Hematology 425
- Molecular Biology 360
- Cardiology and Cardiovascular Medicine 336
- Oncology 270
- Rheumatology 267
Countries citing papers authored by Rinat Yacobi
This map shows the geographic impact of Rinat Yacobi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rinat Yacobi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rinat Yacobi more than expected).
Fields of papers citing papers by Rinat Yacobi
This network shows the impact of papers produced by Rinat Yacobi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rinat Yacobi. The network helps show where Rinat Yacobi may publish in the future.
Co-authorship network of co-authors of Rinat Yacobi
This figure shows the co-authorship network connecting the top 25 collaborators of Rinat Yacobi. A scholar is included among the top collaborators of Rinat Yacobi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rinat Yacobi. Rinat Yacobi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 14 | |
| 3 | 2 | |
| 4 | 30 | |
| 5 | 29 | |
| 6 | Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells (vol 119, pg 1109, 2009) | 0 |
| 7 | [Correlation between the presence of Kras mutation and the presence of the proteins epiregulin and amphiregulin in colon cancer tissue]. | 1 |
| 8 | Cardiotoxicity of the cancer therapeutic agent imatinib mesylatebreakdown → | 858 |
| 9 | 112 | |
| 10 | 97 | |
| 11 | 20 | |
| 12 | A pilot study of the efficacy of oral midazolam for sedation in pediatric dental patients. | 57 |
| 13 | 8 |
About Rinat Yacobi
Rinat Yacobi is a scholar working on Oral Surgery, Rheumatology and Developmental Neuroscience, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Eosinophilic Disorders and Syndromes (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Hematology (425 citations), Genetics (254 citations) and Rheumatology (267 citations). Rinat Yacobi has collaborated with scholars based in Israel, Canada and United States. Frequent co-authors include Richard A. Van Etten, Fred J. Clubb, Jean‐Bernard Durand, Luanda Grazette, Risto Kerkelä, Sergei Shevtsov, Robert Salomon, Joseph Alroy, Anthony Rosenzweig and Stéphanie Pesant. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.